Ionis, AstraZeneca get FDA approval for rare genetic disease treatment
Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for ...
Read moreIonis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for ...
Read moreWelcome back to Distributed Ledger. This is Frances Yue, reporter at MarketWatch. Bitcoin BTCUSD, +0.00% had another leg up this ...
Read moreBetter Therapeutics Inc. shares surged in the extended session Monday after the digital therapeutics company got Food and Drug Administration ...
Read moreEisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline